Population
Group A coxsackieviruses (A13, 15, 18, and 21) virions
Design
Preclinical
Authors
Loading...
VP4 loss impairs viral attachment in vitro; leaves open whether this informs enteroviral myocarditis prevention or antiviral design in humans.
The study demonstrates that the capsid protein VP4 is essential for the adsorption of coxsackievirus A13 to susceptible cells.
Cords et al. (1975) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: